You have probably already looked this up. You searched ozone therapy or hyperbaric oxygen, found a page explaining the biology in confident detail, and then found a thread somewhere saying none of it holds up. Both of those pages can be reading the real research honestly. Three reviews published in 2026 help explain how, and the explanation is not that one side is lying. It is that the two sides are reading different kinds of studies, and those studies measure different things.
Two kinds of evidence, and they do not disagree by accident
Almost everything written in favour of these therapies comes from mechanism research: cell cultures, animal models, markers measured in a laboratory. Almost everything written against them comes from clinical research: people, randomised where possible, measured on whether they could do more afterwards. A narrative review of medical ozone published in Frontiers in Medicine in May 2026 — a few months older than the other papers here — names this directly as a translational gap, and says the mechanisms have been extensively characterised while their direct translation into clinically meaningful outcomes remains uncertain.
That review goes further than most clinic pages would. It concludes that ozone should at present be regarded as an investigational and adjunctive approach rather than a validated therapeutic modality, and notes variable regulatory acceptance across countries and limited endorsement from major health authorities. Ozone therapy is not FDA-approved for the uses discussed on this page, and we would rather say that at the top than bury it.
What the 2026 hyperbaric animal review actually found
In August 2026 a systematic review in BMC Musculoskeletal Disorders pulled together 37 animal studies covering 2,141 animals, all asking what hyperbaric oxygen does to bone, muscle, cartilage, tendon and ligament. Seventeen studies looked at muscle, twelve at tendon and ligament, six at bone and two at cartilage. It is the most complete picture of the preclinical case for hyperbaric oxygen therapy in musculoskeletal tissue that currently exists.
Here is the finding worth sitting with. Histological and molecular outcomes were described as improved more frequently than biomechanical ones. Put plainly: what could be seen under a microscope moved more consistently than whether the tissue was actually stronger. Bone distraction osteogenesis showed the most consistent biomechanical effects. The authors rated risk of bias as high or unclear in most studies, with recurring shortcomings in randomisation, blinding and allocation concealment, and concluded the findings are insufficient to support definitive conclusions.
What happened when the same therapy was measured in injured people
That same month, a systematic review and meta-analysis in Medicina pooled seven studies of hyperbaric oxygen added to standard care for severe traumatic limb injuries. Three were randomised trials and four were observational. Two of the three randomised trials carried a high risk of bias, and all four observational studies a serious one.
The results split along the same line. Wound infection was less frequent with hyperbaric oxygen (odds ratio 0.31, 95% CI 0.22 to 0.45), and so was wound necrosis (odds ratio 0.23, 95% CI 0.12 to 0.45). But time to wound healing did not differ (mean difference −1.44 days, 95% CI −6.70 to 3.82), length of hospital stay did not differ, and the authors state outright that the evidence is insufficient to determine whether hyperbaric oxygen improves complete wound healing. Certainty of evidence was rated low to very low.
The ozone injection research splits the same way
Also in August 2026, a meta-analysis in Frontiers in Medicine pooled seven comparative studies and 751 patients on ozone combined with steroid injection for lumbar disc herniation. Pain intensity fell more with the combination than with control interventions (mean difference −2.27, 95% CI −2.57 to −1.97), and study-defined treatment success was more likely (odds ratio 3.84, 95% CI 2.56 to 5.77). On the face of it, a clear result.
Then the Oswestry Disability Index — the measure of what the patient could actually do afterwards — showed no statistically significant difference (mean difference −0.51, 95% CI −2.82 to 1.81). Safety reporting was too limited to pool at all, and the authors call their own findings preliminary. One thing to be clear about: that paper studied an interventional spine procedure. Venturis Clinic does not perform intradiscal or transforaminal spinal injections. We are citing it because it is the strongest recent human evidence on injected ozone, not because it describes something we do.
Why the same pattern keeps turning up
Three reviews, three different settings, one shape. The measures closest to biology moved more than the measures closest to daily function. That is not a sign of a conspiracy, and it is not a sign that nothing happens. It is what an early evidence base looks like while it is still being built, and it is the single most useful thing a patient can understand about either therapy.
It also explains the internet. A page built from mechanism research can be entirely accurate and still leave you expecting something the clinical research has not demonstrated. A page built from clinical trials can be just as accurate and leave you believing nothing measurable occurs at all. Neither page is lying to you. They are reading different shelves of the same library.
Nobody has standardised the dose, and that is not a small detail
In the animal review, hyperbaric protocols ranged from 1 session to 56. The ozone meta-analysis listed heterogeneous treatment protocols among its reasons for caution, and the ozone narrative review noted that safety data are constrained by a lack of long-term studies and standardised protocols. These are not three papers quibbling. They are three papers saying the studies are not testing one consistent thing.
The practical consequence is this: if two clinics quote you different session counts, neither is necessarily departing from the research, because the research does not agree with itself. What a clinic should be able to tell you is why it chose the protocol it uses, and what it intends to measure in order to decide whether carrying on is worth your money.
Four questions worth asking before you start a course of either therapy
- Is the evidence you are describing to me from animal studies, from human studies, or from both? Ask which.
- What outcome are you going to measure in me, and on what date? Any clinic should be able to answer this before the first session rather than after it.
- How many sessions are planned, and what is the stopping rule if that measure does not move?
- Is this therapy FDA-approved for what we are treating, and if it is not, what does that change about how we proceed?
Who is generally not a good candidate
Hyperbaric oxygen is not appropriate for someone with an untreated collapsed lung, which is a genuine contraindication rather than a caution. It is also a poor fit for anyone who cannot equalise middle ear pressure, anyone whose seizure disorder is not controlled, and anyone whose claustrophobia would prevent them completing a session. Certain chemotherapy agents and some lung disease with air trapping need specialist review first. Ozone given into the blood is generally avoided in pregnancy, in G6PD deficiency, and in uncontrolled thyroid disease.
There is one more exclusion, and it is the honest one. If what you are looking for is a single course of treatment that settles a long-standing problem, the three 2026 reviews above do not support that expectation, and we are not going to tell you otherwise. Candidates are typically evaluated for all of this during a consultation, not from a web page.
Frequently asked questions
Is ozone therapy FDA-approved?
No. Ozone therapy is not FDA-approved for the uses discussed here, and the 2026 Frontiers in Medicine narrative review describes it as investigational and adjunctive rather than a validated therapeutic modality, with limited endorsement from major health authorities. That is worth knowing before you start, and any clinic that leaves it out is leaving out something you are entitled to.
Does the 2026 animal research mean hyperbaric oxygen repairs injured tissue in people?
Not on its own. The BMC Musculoskeletal Disorders review of 37 animal studies found that microscope-level and molecular outcomes improved more often than measures of actual tissue strength, rated most of those studies at high or unclear risk of bias, and concluded the evidence is insufficient for definitive conclusions. Animal findings are a reason to run human trials, not a substitute for them.
How many hyperbaric sessions does the research actually use?
There is no standard. Protocols in the 2026 animal review ranged from a single session to 56. That range is why studies of hyperbaric oxygen are so hard to compare with one another, and why a session count quoted to you should come with a reason attached rather than a round number.
Is hyperbaric oxygen therapy safe?
The 2026 animal review reported no adverse effects on the tissues studied, with barotrauma mentioned as a possible side effect in a small number of cases. In people, the usual issues are pressure-related, most often ear discomfort. Safety still depends on your own history, which is what a consultation is for rather than a page like this one.
Does Venturis Clinic perform ozone injections into spinal discs?
No. We do not perform intradiscal or transforaminal spinal injections, and the lumbar disc meta-analysis cited on this page is here as evidence about injected ozone generally, not as a description of our services. Our ozone therapy and hyperbaric oxygen services are described on their own pages.
What is the difference between EBOO and ozone IV therapy?
They are different delivery routes rather than different strengths of the same thing, and the comparison is covered in detail in our guide to EBOO versus ozone IV therapy in Oklahoma City. Note that the evidence discussed on this page concerns injected and inhaled routes, and does not transfer automatically to blood-based ozone delivery.
Talking it through in Oklahoma City
If you have read the confident version and the dismissive version and want someone to walk you through what the 2026 evidence does and does not show for your own situation, that is a conversation worth having before you spend anything. We will tell you where the research is thin, because on these two therapies a fair amount of it is.
Venturis Clinic
7917 N May Ave, Suite B, Oklahoma City, OK 73120
(405) 848-7246
Serving Oklahoma City, Edmond, Moore, Norman, Yukon, Mustang, Piedmont, Bethany, Warr Acres and Nichols Hills.
This content is for educational purposes only and is not medical advice, diagnosis, or treatment. Individual results vary and no outcome is guaranteed. Venturis Clinic offers regenerative, functional, and alternative medicine services; some therapies discussed are not FDA-approved for the uses described. Talk with a qualified healthcare provider about your specific situation before beginning any treatment.
Sources
- Weinrich L, Tischer T, Schlesiger L, Pachowsky ML, Hoos L. Effects of hyperbaric oxygen therapy on bone, muscle, cartilage, tendon and ligaments in animal studies: a systematic review. BMC Musculoskeletal Disorders 2026;27(1). DOI: 10.1186/s12891-026-10079-6
- Choi KK, Kim Y, Yon DK, Kang WS. Adjunctive hyperbaric oxygen therapy for severe traumatic limb injuries: a systematic review and meta-analysis. Medicina (Kaunas) 2026;62(8):1589. DOI: 10.3390/medicina62081589
- Zhou Y, Yu H. Efficacy of ozone with steroid injection therapy in lumbar disc herniation: meta-analysis. Frontiers in Medicine 2026;13:1891165. DOI: 10.3389/fmed.2026.1891165
- Lietz-Kijak D, et al. Medical ozone: mechanisms, biological effects and clinical evidence — a narrative review. Frontiers in Medicine 2026;13:1859221. DOI: 10.3389/fmed.2026.1859221
